Staar Surgical Co's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Staar Surgical Co in the second quarter 2026?
Staar Surgical Co achieved a return on average equity (ROE) of 1.08 % in its second quarter 2026, this is above STAA's average return on equity of -3.89%.
Staar Surgical Co shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $354 million

ROE has advanced compared to -6.07% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 60 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2514 to 2575.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 03 2026) II. Quarter	(Apr 03 2026) I. Quarter	(Jan 02 2026) IV. Quarter	(Sep 26 2025) III. Quarter	(Jun 27 2025) II. Quarter
Y / Y Equity Change	8.56 %	0.68 %	-13.38 %	-17.36 %	-
Y / Y Net Income Change	-	-	-	-10.98 %	-
Net Income (TTM) in Millions	4	-21	-80	-96	-95
Return On Equity (TTM)	1.08 %	-6.07 %	-23.24 %	-26.81 %	-25.2 %
STAA's Total Ranking	# 2575	# 2514	# 2263	# 2511	# 2174
Equity (TTM) in Millions	365	352	344	354	337
Seq. Equity Change	3.7 %	2.38 %	-2.71 %	5.11 %	-3.83 %
Seq. Net Income Change	54.78 %	-	-	-	-

Back to STAA Management Effectiveness >> STAA's 5 Years Annual ROE >> Compare STAA ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 61
Sector	# 183
Overall	# 2575

Return On Equity Statistics
High	Average	Low
13.07 %	-3.89 %	-33.5 %
(Sep 30 2022)		(Sep 30 2016)

STAA Annual Return On Equity	(Jan 02 2026) 2025	(Dec 27 2024) 2024	(Dec 29 2023) 2023	(Dec 30 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	344	397	386	332	259
Y / Y Equity Change	-13.38 %	2.95 %	16.18 %	28.48 %	31.1 %
Net Income in Millions	-80	-20	21	39	25
Y / Y Net Income Change	-	-	-44.92 %	58.18 %	314.36 %
Return On Equity	-23.37 %	-5.09 %	5.53 %	11.67 %	9.48 %

Back to STAA Management Effectiveness >> STAA's 5 Years Annual ROE >> Compare STAA ROE to its Competitors

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
STAA's' Return on Equity at Yahoo Finance
STAA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for STAA's Competitors
Subscribers only: Roe for Staar Surgical Co's Suppliers
Subscribers only: Return On Equity for STAA's Customers

Companies with similar Return On Equity at Jul 03 2026, within Healthcare Sector	ROE
Immucell Corporation	2.68 %
Surgery Partners Inc	2.63 %
Mimedx Group Inc	2.61 %
Cormedix Inc	2.18 %
Atricure Inc	2.14 %
Pacira Biosciences inc	2.13 %
Warby Parker Inc	2.06 %
Repligen Corp	1.98 %
Arvinas Inc	1.91 %
Waters Corporation	1.88 %
Omada Health Inc	1.84 %
Radnet Inc	1.42 %
Icu Medical Inc	1.41 %
Biomarin Pharmaceutical Inc	1.18 %
Staar Surgical Co	1.08 %
Champions Oncology Inc	0.94 %
Delcath Systems Inc	0.46 %

Date modified: 2026-09-08T22:25:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.